A detailed history of Oak Thistle LLC transactions in Cerus Corp stock. As of the latest transaction made, Oak Thistle LLC holds 54,101 shares of CERS stock, worth $97,381. This represents 0.03% of its overall portfolio holdings.

Number of Shares
54,101
Holding current value
$97,381
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.7 - $2.39 $91,971 - $129,301
54,101 New
54,101 $94,000
Q1 2024

Apr 18, 2024

BUY
$1.66 - $2.42 $19,297 - $28,132
11,625 New
11,625 $21,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $319M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Oak Thistle LLC Portfolio

Follow Oak Thistle LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Thistle LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Thistle LLC with notifications on news.